Meta-analysis of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer

被引：0
|
作者：
Nishikawa, K. [1 ]
Koizumi, W. [2 ]
Tsuburaya, A. [3 ]
Yamanaka, T. [4 ]
Morita, S. [5 ]
Fujitani, K. [6 ]
Akamaru, Y. [7 ]
Shimada, K. [8 ]
Hosaka, H. [9 ]
Nakayama, N. [10 ]
Miyashita, Y. [11 ]
Tsujinaka, T. [12 ]
Sakamoto, J. [13 ]
机构：
[1] Natl Hosp Org Osaka Natl Hosp, Surg, Osaka, Japan
[2] Kitasato Univ, Sch Med, Gastroenterol, Sagamihara, Kanagawa, Japan
[3] Tsuboi Canc Ctr Hosp, Surg, Koriyama, Fukushima, Japan
[4] Yokohama City Univ Med, Biostat, Yokohama, Kanagawa, Japan
[5] Kyoto Univ, Grad Sch Med, Biomed Stat & Bioinformat, Kyoto, Japan
[6] Osaka Gen Med Ctr, Surg, Osaka, Japan
[7] Ikeda Municippal Hosp, Surg, Ikeda, Osaka, Japan
[8] Showa Univ, Kouto Toyosu Hosp, Internal Med, Tokyo, Japan
[9] Gunma Prefectural Canc Ctr, Gastroenterol, Ohta, Gunma, Japan
[10] Kanagawa Canc Ctr, Gastroenterol, Yokohama, Kanagawa, Japan
[11] Epidemiol & Clin Res Informat Network, Ctr Data, Okazaki, Aichi, Japan
[12] Kaizuka City Hosp, Surg, Kaizuka, Japan
[13] Tokai Cent Hosp, Surg, Kakamigahara, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
679P
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer
    Liuting Yang
    Xiaoyue Jiang
    Han Yan
    Yingying Li
    Hongchao Zhen
    Bingmei Chang
    Seyed Kariminia
    Qin Li
    BMC Gastroenterology, 18
  • [12] Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer
    Yang, Liuting
    Jiang, Xiaoyue
    Yan, Han
    Li, Yingying
    Zhen, Hongchao
    Chang, Bingmei
    Kariminia, Seyed
    Li, Qin
    BMC GASTROENTEROLOGY, 2018, 18
  • [13] Fractional weekly administration of irinotecan and cisplatin as a second-line treatment for advanced gastric cancer.
    Jeung, HC
    Noh, SH
    Lee, JI
    Chung, HC
    Rha, SY
    Roh, JK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 327S - 327S
  • [14] Phase II study of biweekly irinotecan and cisplatin as second-line chemotherapy in pretreated patients with advanced gastric cancer.
    Baek, JH
    Kim, JG
    Sohn, SK
    Song, HS
    Kwon, KY
    Do, YR
    Ryu, HM
    Bae, SH
    Park, GW
    Lee, KH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 325S - 325S
  • [15] Biweekly irinotecan and cisplatin as second-line chemotherapy in pretreated patients with advanced gastric cancer: A multicenter phase II study
    Baek, JH
    Kim, JG
    Sohn, SK
    Kim, DH
    Lee, KB
    Song, HS
    Kwon, KY
    Do, YR
    Ryoo, HM
    Bae, SH
    Park, KU
    Kim, MK
    Lee, KH
    Hyun, MS
    Chung, HY
    Yu, W
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (06) : 966 - 970
  • [16] Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial
    Nishikawa, Kazuhiro
    Fujitani, Kazumasa
    Inagaki, Hitoshi
    Akamaru, Yusuke
    Tokunaga, Shinya
    Takagi, Masakazu
    Tamura, Shigeyuki
    Sugimoto, Naotoshi
    Shigematsu, Tadashi
    Yoshikawa, Takaki
    Ishiguro, Tohru
    Nakamura, Masato
    Morita, Satoshi
    Miyashita, Yumi
    Tsuburaya, Akira
    Sakamoto, Junichi
    Tsujinaka, Toshimasa
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (07) : 808 - 816
  • [17] Single-agent irinotecan as second-line treatment for advanced gastric cancer
    Kanat, O
    Evrensel, T
    Manavoglu, O
    Demiray, M
    Kurt, E
    Gonullu, G
    Kiyici, M
    Arslan, M
    TUMORI JOURNAL, 2003, 89 (04): : 405 - 407
  • [18] Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer
    Takahari, Daisuke
    Shimada, Yasuhiro
    Takeshita, Shigeyuki
    Nishitani, Hitoshi
    Takashima, Atsuo
    Okita, Natsuko
    Hirashima, Yoshinori
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shirao, Kuniaki
    GASTRIC CANCER, 2010, 13 (03) : 186 - 190
  • [19] Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer
    Daisuke Takahari
    Yasuhiro Shimada
    Shigeyuki Takeshita
    Hitoshi Nishitani
    Atsuo Takashima
    Natsuko Okita
    Yoshinori Hirashima
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Kuniaki Shirao
    Gastric Cancer, 2010, 13 : 186 - 190
  • [20] Phase II study on the combination of irinotecan plus cisplatin as a second-line therapy in patients with advanced or recurrent gastric cancer
    Rino, Yasushi
    Yukawa, Norio
    Sato, Tsutomu
    Oshima, Takashi
    Tanabe, Hiroyasu
    Yamamoto, Yuji
    Matsukawa, Hiroshi
    Shiraishi, Ryuji
    Imada, Toshio
    Masuda, Munetaka
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (04) : 749 - 752
12345